Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Appointed director
Quarterly results
Director departure
Inv. presentation
|
|
China Biologic Products Holdings, Inc. (CBPO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2023 |
SC 13D/A
| Parfield International Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| Parfield International Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| Centurium Capital Partners 2018, L.P. reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| Chow Joseph reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| CITIC Capital Holdings Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/21/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/14/2021 |
SC 13D/A
| Parfield International Ltd reports a 5.5% stake in China Biologic Products Holdings, Inc. |
| 01/08/2021 |
SC 13D/A
| Chow Joseph reports a 13.8% stake in China Biologic Products Holdings, Inc. |
| 01/08/2021 |
SC 13D/A
| PW Medtech Group Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 01/04/2021 |
SC 13D/A
| Parfield International Ltd reports a 5.5% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| Chow Joseph reports a 3.8% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| Centurium Capital Partners 2018, L.P. reports a 25.6% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| PW Medtech Group Ltd reports a 9.7% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| CITIC Capital Holdings Ltd reports a 12.8% stake in China Biologic Products Holdings, Inc. |
| 11/23/2020 |
SC 13D/A
| Temasek Holdings Ltd reports a 3.2% stake in China Biologic Products Holdings, Inc. |
| 11/23/2020 |
SC 13D/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 7.6% stake in China Biologic Products Holdings, Inc. |
| 11/20/2020 |
SC 13D/A
| Parfield International Ltd reports a 6.3% stake in China Biologic Products Holdings, Inc. |
| 11/20/2020 |
SC 13D/A
| CITIC Capital Holdings Ltd reports a 9.7% stake in China Biologic Products Holdings, Inc. |
| 11/20/2020 |
SC 13D/A
| Chow Joseph reports a 0.4% stake in China Biologic Products Holdings, Inc. |
| 11/20/2020 |
SC 13D/A
| PW Medtech Group Ltd reports a 13.7% stake in China Biologic Products Holdings, Inc. |
| 11/20/2020 |
SC 13D/A
| Centurium Capital Partners 2018, L.P. reports a 27.6% stake in China Biologic Products Holdings, Inc. |
| 10/28/2020 |
SC 13D/A
| Parfield International Ltd reports a 6.3% stake in China Biologic Products Holdings, Inc. |
| 10/28/2020 |
SC 13D/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 7.7% stake in China Biologic Products Holdings, Inc. |
| 10/28/2020 |
SC 13D/A
| Centurium Capital Partners 2018, L.P. reports a 27.7% stake in China Biologic Products Holdings, Inc. |
| 10/28/2020 |
SC 13D/A
| PW Medtech Group Ltd reports a 13.8% stake in China Biologic Products Holdings, Inc. |
| 10/28/2020 |
SC 13D/A
| CITIC Capital Holdings Ltd has filed a Schedule 13D for China Biologic Products Holdings, Inc. |
| 09/18/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 7.7% stake in China Biologic Products Holdings, Inc. |
| 09/18/2020 |
SC 13D/A
| Temasek Holdings Ltd reports a 3.2% stake in China Biologic Products Holdings, Inc. |
| 09/17/2020 |
SC 13D/A
| Parfield International Ltd reports a 6.3% stake in China Biologic Products Holdings, Inc. |
| 09/17/2020 |
SC 13D/A
| CITIC Capital Holdings Ltd reports a 9.7% stake in China Biologic Products Holdings, Inc. |
| 09/17/2020 |
SC 13D/A
| PW Medtech Group Ltd reports a 13.8% stake in China Biologic Products Holdings, Inc. |
| 09/17/2020 |
SC 13D/A
| Centurium Capital Partners 2018, L.P. reports a 27.7% stake in China Biologic Products Holdings, Inc. |
| 05/11/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|
|